Table of Contents
- Overview
- Prevention
- Images
The DTaP vaccine is a "3-in-1" vaccine that protects against
IMMUNIZATION SCHEDULE
Pertussis vaccination is one of the recommended childhood immunizations and should begin during infancy. Pertussis immunization is generally required before starting school. A five-dose series is recommended.
DTaP immunization is series of injections given to children at ages 2 months, 4 months, 6 months and 15-18 months. A booster is given before starting school (age 4-6 years). A different vaccine, the
In spring 2005, the FDA approved 2 new booster vaccines (Boostrix and Adacel) against pertussis in combination with tetanus and diphtheria for adolescents and adults. This article focuses primarily on infant DtaP vaccination.
BENEFITS
Pertussis vaccine is highly effective for the prevention of pertussis. Immunized persons who develop pertussis usually have a milder case than nonimmunized people.
DTaP vaccine can be safely given to infants.
RISKS
DTaP may cause mild side effects (
DTaP causes moderate complications in less than 1% of injections. These complications include:
- High
fever greater than 105 degrees F (1 in 16,000 children) - Non-stop crying for more than 3 hours (1 in 1,000 children)
- Seizure (1 in 14,000 children)
Images
Review Date: 06/16/2005
Reviewed By: Anuradha Banerjee, M.D., Department of Pediatrics, University of
California, San Francisco, San Francisco, CA. Review provided by
VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)
